FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.
What happened
FDA reviewed the Clean Zone website on June 4, 2024 and found the Clean Zone CPAP Sanitizer marketed to disinfect CPAP machines, tubes, and masks using activated oxygen, with a claim that it kills 99% of germs and bacteria. FDA said the product is a device and that the firm lacks PMA or IDE approval; it also said the firm did not submit a 510(k) premarket notification. FDA rejected the firm’s 2021 claim that the product was exempt as a Class I general purpose disinfectant, saying CPAP devices and accessories are semi-critical and ozone treatment poses patient-safety and device-performance risks.
What FDA found
The Clean Zone CPAP Sanitizer is a medical device under the law because it is intended to prevent disease or affect body function.
section 201(h) of the Act, 21 U.S.C. § 321(h)The company lacks an approved premarket approval application or investigational device exemption for the device, so FDA considers it adulterated.
section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B); section 515(a), 21 U.S.C. § 360e(a); section 520(g), 21 U.S.C. § 360j(g)The company introduced the device into interstate commerce for commercial distribution without a 510(k) premarket notification, so FDA considers it misbranded.
section 502(o) of the Act, 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k); 21 CFR 807.81(a)(1)
What FDA wants
FDA requests that the company cease activities that result in misbranding or adulteration of the Clean Zone CPAP Sanitizer. The company must notify FDA in writing within 15 business days of steps taken to address the violations and prevent recurrence, including corrective actions and a timetable if needed.
Who should pay attention
- CPAP device and accessory makers
- companies selling ozone-based sanitizers
- distributors and retailers of medical devices
This is a summary. Read the original letter on fda.gov.